Goyal Vinita
From the Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Obstet Gynecol. 2009 May;113(5):1117-1123. doi: 10.1097/AOG.0b013e31819dbfe2.
To determine the risk of uterine rupture when using misoprostol for second-trimester abortion in women with a history of cesarean delivery.
MEDLINE, EMBASE, CINAHL, LILACS, and the Cochrane Library were searched systematically for all articles published before September 2008.
Sixty-three articles were found using the above data sources. I excluded case reports, narrative reviews or commentaries, studies that excluded women with a history of cesarean delivery, studies with unrelated outcomes, studies not conducted in humans, and studies that were not available in English. The remaining 16 studies that described misoprostol use for second-trimester abortion in women with a history of cesarean delivery were examined.
TABULATION, INTEGRATION, AND RESULTS: The number of participants with and without cesarean delivery, regimen of medical abortion used, and cases of uterine rupture were reviewed. To estimate the risk of uterine rupture in women with prior cesarean delivery undergoing second-trimester abortion with misoprostol and number needed to harm, I pooled the results of all 16 studies. The risk of uterine rupture in women with prior cesarean delivery was 0.28% (95% confidence interval [CI] 0.08-1.00%). The risk of uterine rupture in women without prior cesarean delivery was 0.04% (95% CI 0.01-0.20%). Based on these risks, if 414 women with a history of cesarean delivery were given misoprostol for second-trimester abortion, one would experience uterine rupture.
The risk of uterine rupture among women with a prior cesarean delivery undergoing second-trimester abortion using misoprostol is less than 0.3%. This may be acceptable to both patients and providers.
确定有剖宫产史的女性在孕中期使用米索前列醇进行流产时子宫破裂的风险。
对MEDLINE、EMBASE、CINAHL、LILACS和考科蓝图书馆进行系统检索,查找2008年9月之前发表的所有文章。
通过上述数据来源共找到63篇文章。我排除了病例报告、叙述性综述或评论、排除有剖宫产史女性的研究、结果不相关的研究、非人体研究以及非英文研究。对其余16项描述有剖宫产史女性在孕中期使用米索前列醇进行流产的研究进行了审查。
制表、整合与结果:回顾了有和没有剖宫产史的参与者人数、所使用的药物流产方案以及子宫破裂病例。为了估计有剖宫产史的女性在孕中期使用米索前列醇进行流产时子宫破裂的风险以及伤害所需人数,我汇总了所有16项研究的结果。有剖宫产史女性子宫破裂的风险为0.28%(95%置信区间[CI] 0.08 - 1.00%)。无剖宫产史女性子宫破裂的风险为0.04%(95% CI 0.01 - 0.20%)。基于这些风险,如果414名有剖宫产史的女性在孕中期使用米索前列醇进行流产,将会有一人发生子宫破裂。
有剖宫产史的女性在孕中期使用米索前列醇进行流产时子宫破裂的风险小于0.3%。这对患者和医疗服务提供者来说可能都是可以接受的。